Richard Lloyd, MD
Medical Oncologist
Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Dr. Richard Lloyd graduated from the Stanford University School of Medicine. He did his internship at the VA Medical Center and completed his residency program at the University of Arizona. Then, he did a fellowship at the University of Arizona. He is specialized in Medical Oncology and board certified in Internal Medicine and Oncology. Dr. Lloyd has been in practice for more than 20 years and is affiliated with the St. Jude Medical Center. During his career, he has also contributed to various research papers.
Stanford University School of Medicine
Medical School
VA Medical Center
Internship
University of Arizona
Residency
University of Arizona
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
CA State Medical License 1977 - 2018
The stress granule protein G3BP1 recruits PKR to promote multiple innate immune antiviral responses.
Reineke, L. C.,Lloyd, R. E.; J. Virol.. 2014 Dec 19.
See more >>Cytoplasmic RNA Granules and Viral Infection.
Tsai, W. C.,Lloyd, R. E.; Annu Rev Virol. 2014 Nov 03.
See more >>mRNA Decapping Enzyme 1a (Dcp1a)-induced Translational Arrest through Protein Kinase R (PKR) Activation Requires the N-terminal Enabled Vasodilator-stimulated Protein ...
Dougherty, J. D.,Reineke, L. C.,Lloyd, R. E.; J. Biol. Chem.. 2014 Jan 03.
See more >>